Clinical Trial Update: An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study of abiraterone acetate in men with advanced prostate cancer after failure of androgen deprivation therapy and docetaxel; safety and efficacy resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zytiga (abiraterone acetate)

Snippet

Sponsor: Cougar Biotechnology, Inc. | Conditions: Prostate Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-08-15